News

A new treatment approach for fetal and neonatal alloimmune thrombocytopenia (FNAIT) uses specific antibody levels.

Family-centered care in NICUs affects emotional, social and system-level outcomes, not just medical survival.

Adopting the updated guidelines offers significant opportunities to reduce unnecessary platelet transfusions, which are used to treat FNAIT.

Clinical trials and real-world data have unique strengths and weaknesses when it comes to advancing maternity care for diseases like FNAIT.

A recent study found that several forms of exercise, including yoga and Pilates, may alleviate symptoms of perinatal anxiety and depression.

Pregnancy screening can identify families at risk for FNAIT early, allowing closer monitoring before dangerous bleeding occurs in newborns.

Researchers have developed a novel CRISPR-based method to better understand genetic mutations in IPDs, a differential diagnosis for FNAIT.

Unscheduled cesarean delivery can carry a significant emotional burden with consequences for maternal mental health, researchers stated.

Often-overlooked platelet proteins may trigger harmful immune responses in FNAIT, prompting the need to combine antibody tests.

Allergic reactions and fever are the most common side effects of blood transfusions seen in children, according to a recent study.